Acetazolamide
Brand names: Diamox
Acetazolamide is a carbonic anhydrase inhibitor used in glaucoma, idiopathic intracranial hypertension, certain epilepsies and the prevention of acute mountain sickness.
Adult dose
Paediatric dose
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to acetazolamide or any excipient
- Depressed sodium and/or potassium blood levels
- Marked kidney and liver disease or dysfunction
- Suprarenal gland failure
- Hyperchloraemic acidosis
- Hepatic cirrhosis (risk of hepatic encephalopathy)
- Long-term use in chronic non-congestive angle-closure glaucoma
- Hypersensitivity to sulphonamides
Side effects
- Paraesthesia (tingling in extremities), dizziness, headache, drowsiness
- Metabolic acidosis, electrolyte imbalance, thirst
- Nausea, vomiting, diarrhoea, taste disturbance
- Blood dyscrasias (thrombocytopenia, leukopenia, aplastic anaemia, agranulocytosis)
- Transient myopia, choroidal effusion/detachment; skin reactions (urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis, AGEP)
Interactions
- May potentiate effects of folic acid antagonists
- May potentiate hypoglycaemics and oral anticoagulants
- Concurrent aspirin may cause severe acidosis and increased CNS toxicity
Clinical monograph
How it works
By inhibiting carbonic anhydrase it reduces aqueous humour and cerebrospinal fluid production and promotes renal bicarbonate excretion, producing a mild diuresis and metabolic acidosis.
Prescribing in practice
- It is a sulfonamide derivative and is contraindicated in sulfonamide hypersensitivity; it can cause electrolyte disturbance, metabolic acidosis and, rarely, serious blood dyscrasias and Stevens-Johnson syndrome.
- Use with caution and dose adjustment in renal or hepatic impairment, and avoid in marked electrolyte imbalance.
- Paraesthesia of the extremities and an altered taste of carbonated drinks are common, dose-related effects.
Monitoring
Monitor electrolytes (including potassium) and consider periodic full blood count on prolonged therapy.
Counselling the patient
- Tingling of the hands and feet and a metallic taste are common and usually harmless.
- Report a sore throat, fever, rash or unusual bruising.
- Tell your prescriber if you have any allergy to sulfonamide antibiotics.
Evidence & guidelines
Acetazolamide is a recognised treatment for idiopathic intracranial hypertension and glaucoma in current prescribing references.
Reference: NICE CKS Glaucoma; ABN IIH guideline 2018; SmPC Diamox; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
- BALL Score for Relapsed/Refractory CLL · Leukaemia
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS